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Introduction
Cadmium (Cd) is a heavy metal that ranks among the 
top ten chemicals in the Agency for Toxic Substances and 
Disease Registry priority list of hazardous substances.1 It 
is widespread in the environment, found in byproducts of 
industrial processes, contaminated water or soil, certain foods, 
and tobacco products.2 Cd is a known lung carcinogen and a 
putative carcinogen in other tissues including the liver, prostate, 
kidney, bladder, stomach, and pancreas.3-5 In addition to its role 
as a carcinogen, Cd has also been associated with other health 
endpoints, including developmental effects early in life. For 
example, prenatal Cd exposure has been inversely associated 
with fetal growth parameters such as newborn length, weight, 
height, and head circumference,6-13 as well as adverse cognitive 
developmental effects later in life.12,14
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cadmium (cd) is prevalent in the environment yet understudied as a developmental toxicant. cd partially crosses the 
placental barrier from mother to fetus and is linked to detrimental effects in newborns. here we examine the relationship 
between levels of cd during pregnancy and 5-methylcytosine (5mc) levels in leukocyte DNa collected from 17 mother-
newborn pairs. The methylation of cytosines is an epigenetic mechanism known to impact transcriptional signaling 
and influence health endpoints. a methylated cytosine-guanine (cpG) island recovery assay was used to assess over 
4.6 million sites spanning 16 421 cpG islands. Exposure to cd was classified for each mother-newborn pair according 
to maternal blood levels and compared with levels of cotinine. subsets of genes were identified that showed altered 
DNa methylation levels in their promoter regions in fetal DNa associated with levels of cd (n = 61), cotinine (n = 366), or 
both (n = 30). Likewise, in maternal DNa, differentially methylated genes were identified that were associated with cd 
(n = 92) or cotinine (n = 134) levels. While the gene sets were largely distinct between maternal and fetal DNa, functional 
similarities at the biological pathway level were identified including an enrichment of genes that encode for proteins that 
control transcriptional regulation and apoptosis. Furthermore, conserved DNa motifs with sequence similarity to specific 
transcription factor binding sites were identified within the cpG islands of the gene sets. This study provides evidence for 
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Health effects associated with moderate to low levels of 
Cd exposure are of growing concern, particularly among sus-
ceptible populations such as pregnant women and children.15 
Highlighting this issue, among pregnant women studied in the 
Fourth National Report on Human Exposure to Environmental 
Chemicals (NHANES IV), 66% had detectable blood Cd levels 
with an average level of 0.22 μg/L.16 The presence of Cd in the 
blood is particularly concerning as it has a half-life ranging up 
to 10 y.17 Cd is a component of cigarette smoke and concur-
rent exposure occurs. In utero exposure to both Cd and ciga-
rette smoke is associated with lower newborn birth weight6,9,18 
where Cd has been suggested to be the component of cigarette 
smoke that affects fetal skeletal growth.19 Cotinine, the primary 
metabolite of nicotine and biomarker of cigarette smoke expo-
sure, is a reliable measure of actual dose received with a half-life 
of less than 1 d.20,21 Thus, cotinine is a general measure of recent 
exposure to tobacco products, whereas Cd can represent long-
term and/or historic tobacco exposure. For non-smokers, diet is 
the major source of Cd exposure.17
The mechanism(s) of action of the detrimental health effects 
related to prenatal Cd exposure are not well established. An epi-
genetic mechanism has been hypothesized,22 but is understud-
ied. The addition or removal of methyl groups from cytosine at 
the 5′ position (5mC) is an epigenetic mechanism that plays a 
key role in mediating gene expression and subsequent biological 
processes,23 possibly contributing to subsequent health effects 
resulting from environmental toxicant exposure. Indeed there 
is evidence from animal and cell culture studies that Cd alters 
DNA methyltransferase activity and subsequently DNA meth-
ylation patterns.3,22,24-29 In addition, prenatal tobacco smoke 
exposure is a known modifier of DNA methylation patterns,30-32 
and is therefore an important consideration in this study.
In an effort to understand potential impacts of prenatal Cd 
exposure, in the present study we assess DNA methylation in 
blood leukocytes and distinguish between Cd- and cotinine-
associated changes in a cohort of mother-baby pairs from 
Durham County, North Carolina. Maternal cotinine and 
Cd levels were used to compare and contrast the DNA 
methylation levels associated with either contaminant, 
enabling the differentiation between Cd-specific patterns in 
DNA methylation from those associated with cotinine. DNA 
methylation changes of more than 16 000 promoter-based 
cytosine-phosphate-guanine (CpG) islands were assessed in 
fetal and maternal DNA associated with maternal and thus in 
utero Cd and cotinine levels.
Results
This study consisted of 34 subjects, 17 mother–newborn 
pairs, selected as a nested cohort from the CEHI Healthy 
Figure 1. heat map of genes with differential DNa methylation levels in fetal and maternal DNa associated with cd (A), or cotinine (B). Venn diagram 
representing the total number of cd-or cotinine-associated genes in fetal DNa (C) or maternal DNa (D). heat maps represent average DNa methylation 
levels of exposure-associated gene sets. Data are z-score normalized for each gene. Individuals are ordered from left to right based on increasing level of 
exposure. Red indicates a relative increase in average DNa methylation and blue represents a relative decrease in average DNa methylation. In the Venn 
diagrams, the number in parentheses indicates the number of hypomethylated genes contained in each set. LE, lower exposed; hE, higher exposed; 
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Pregnancy, Healthy Baby study in Durham, North Carolina. 
The pairs were selected from the larger cohort based on stratified 
maternal blood Cd levels. Maternal and infant characteristics 
are presented in Table 1. The average maternal age was 
28 y. Most of the women had more than one child (n = 13; 
76.5%), inclusive of the infants described in this study. There 
were similar proportions of male (n = 9; 52.9%) and female 
children (n = 8; 47.1%). All newborns, with one exception, 
had a birth weight greater than 2500 g (range: 2495–3740 g). 
Levels of maternal Cd ranged from below the detection limit 
to 1.05 μg/L with an average maternal blood concentration of 
0.44 μg/L. Ten women in the study had Cd levels above the 
NHANES median level in pregnant women and were classified 
as the “higher cadmium-exposed” group (See Materials and 
Methods). Maternal cotinine levels ranged from below the 
detection limit to 166.96 μg/L with an average of 14.5 μg/L. 
While 11 women had detectable blood levels of cotinine, only 
two had levels above 10 μg/L, a level associated with active or 
passive smoking activity.20 The two individuals with elevated 
cotinine reported active smoking during pregnancy. As we 
were also interested in the effect of exposure due to second-
hand or inactive smoking, cotinine exposure was classified as 
any detectable level vs. none. Eleven women had a detectable 
level of cotinine and were classified as “cotinine-exposed.” The 
exposure data for each of the 17 mother-baby pairs is provided 
(Tables S1 and S2).
Regression analysis revealed that maternal Cd or cotinine 
levels did not vary significantly with respect to maternal age, 
race, parity, child’s sex, or birth weight. Exclusion of the low 
birth weight infant from the data set did not significantly 
affect the results (data not shown). Generally, younger women 
had higher levels of Cd, but this finding was not statistically 
significant (P > 0.05). Spearman rank correlation revealed a 
positive relationship between maternal serum cotinine and Cd 
(r = 0.45, P = 0.07).
Cd-associated gene-specific DNA methylation
Methylated maternal and newborn DNA was isolated using 
a methyl-CpG-binding domain protein complex (MBD2b/
MBD3L1) and hybridized onto Affymetrix Human Promoter 
1.0R arrays. These arrays contain more than 4.6 million probes 
Figure 2. significantly enriched DNa motifs identified within the cd and cotinine-associated gene lists in fetal DNa (A) and maternal DNa (B) as identi-
fied by MEME. The motifs shown have standard orientation 5′ to 3′. Estimates of sequence conservation at each nucleotide position within the motif are 
























that cover more than 25 500 human gene promoter regions. 
Computational methods were used to summarize the DNA 
methylation levels at a gene-specific CpG island level annotated 
to the reference Human Genome 18 (HG18) as in our recent 
publications33,34 (see Materials and Methods). More than 16 000 
CpG islands were included in this study.
Prior to analysis for the exposures of interest, differences in 
average DNA methylation levels associated with maternal age, 
race, and infant sex were identified. Analysis of the maternal 
DNA revealed there was a significant difference in gene-specific 
methylation levels associated with maternal age (n = 596 genes) 
and race (n = 83 genes). In fetal DNA, there was a significant 
difference in gene-specific DNA methylation levels associated 
with maternal age (n = 39 genes), race (n = 949 genes), and infant 
sex (n = 176 genes) (Table S3).
In relation to newborn environmental exposures of Cd and 
cotinine, two gene sets were identified with significantly different 
average DNA methylation abundances in fetal DNA including a 
Cd-associated gene set (n = 61) and a cotinine-associated gene set 
(n = 366) (Fig. 1A and B; Table S4). Of these, one gene showed 
hypomethylation with increasing Cd, and five genes showed 
hypomethylation with respect to increasing cotinine (Fig. 1C). 
A total of 30 genes overlapped between the Cd and cotinine gene 
sets and all were hypermethylated (Fig. 1C; Table S4).
In maternal DNA, distinct sets of Cd-associated (n = 92) 
or cotinine-associated genes (n = 134) were identified (Fig. 1A 
and B; Table S5). Of these, 11 of the 92 Cd-associated 
differentially methylated genes were hypomethylated, whereas 
four  of 134 cotinine-associated genes were hypomethylated. 
There were no overlapping genes between the Cd- or cotinine-
associated genes in maternal DNA (Fig. 1D).
A comparison of the Cd-associated genes between maternal 
and fetal DNA showed no overlap. Very few (n = 12) of the 
cotinine-associated genes were differentially methylated in 
both fetal and maternal DNA (data not shown). The majority 
of differentially methylated genes showed increasing promoter 
methylation with increasing Cd or cotinine level for both fetal 
and maternal DNA (Fig. 1A and B).
In addition to identifying genes that are differentially 
methylated and associated with Cd or cotinine levels, a 
comparison was also performed between the DNA methylomes 
of the women and their newborns. Regardless of environmental 
exposure, this comparison of the 34 individuals’ methylomes 
showed that there were 12 820 genes significantly differentially 
methylated between fetal and maternal DNA that were not due 
to differences in maternal age, race, or infant sex (Fig. S1). All of 
the 12 820 genes showed lower average methylation abundance 
in maternal DNA when compared with fetal DNA.
Differential methylation does not reflect shifts in leukocyte 
cell types
The Cd- and cotinine-associated gene sets were compared 
with known differentially methylated regions (DMRs) that 
correspond to shifts in the abundance of white blood cell types.35 
Within a list of 500 genes with DMRs known to predict cell 
type in an adult population, 227 of these genes were contained 
on the MIRA array. No blood cell type-associated genes were 
contained in the maternal Cd- or cotinine-associated genes 
lists in this study. A single gene, UNC84 domain containing 1 
(UNC84A), was present in the Cd-associated fetal DNA gene set 
and 4 genes: neutrophil cytosolic factor 4 (NCF4), CBP80/20-
dependent translation initiation factor (KIAA0427), sorting 
nexin 8 (SNX8), and scavenger receptor class F (SCARF) were 
present in the cotinine-associated gene set in fetal DNA.
Biological functions are enriched among differentially 
methylated genes
The identified Cd- and cotinine-associated gene sets in 
mother–baby pairs were analyzed to determine whether they 
encode proteins with similar functionality in the cell. Each of 
the gene sets was analyzed for enriched biological functions 
using two independent methods (see Materials and Methods). 
The most significantly enriched biological functional categories 
were gene expression, cell cycle, cell death, and nervous system 
development (Table 2). Interestingly, while there was no overlap 
between the individual gene sets, genes that encode proteins 
that play a role in regulation of transcription were enriched 
among Cd-associated genes in both fetal and maternal DNA 
(P < 0.001). Apoptosis was an enriched biological process in the 
Cd and cotinine-associated gene sets identified as differentially 
methylated within both maternal and fetal DNA (P < 0.05). 
Specifically, there were 14 apoptosis-associated genes including 
proline rich 13 (PRR13) in the fetal gene set and 20 additional 
genes among the maternal gene set (Table S6).
Common DNA motifs identified in gene sets
We hypothesized that the identified differentially methylated 
genes may contain common underlying sequences or motifs. 
To examine this, the promoter regions of the CpG islands for 
each of the differentially methylated genes were analyzed for 
statistically enriched common sequence patterns (e.g., motifs). 
The motifs were then compared with known transcription 
Table 1. characteristics of mother-newborn pairs (n = 34 subjects)
Mean ± SD (range)/N (%)
Maternal cadmium (μg/L) 0.44 ± 0.31 (0–1.05)
Maternal cotinine (μg/L) 14.5 ± 42.23 (0–166.96)












Birth weight (g) 3210 ± 377 (2495–3740)
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factor binding sites. Among the Cd- and cotinine-associated gene 
sets, significantly enriched motifs representing conserved DNA 
sequences were identified (Fig. 2). The conserved motifs showed 
sequence similarity to binding sites for several transcription factors 
including: transcription factor 7-like 1 (TCF7L1 also known 
as TCF3), metal-responsive transcription factor-1 (MTF-1), 
transcription factor AP-2-eplison (TCFAP2E), and serum 
response factor (SRF) (Table 3). Notably, for the Cd-associated 
gene sets identified both in maternal and fetal DNA, the enriched 
motifs had significant sequence similarity to the binding sites of 
MTF-1 and TCF7L1.
Validation of MIRA DNA methylation results
Validation of the MIRA-based methylation results was 
performed using two methodologies for both fetal and maternal 
DNA. First using a gene-specific analysis, the promoter region of 
the apoptosis-associated PRR13 gene was targeted for methylation-
specific quantitative polymerase chain reaction (qPCR)-based 
analysis. Primers were designed to amplify the promoter region 
comparable to the MIRA-assessed site (see Materials and 
Methods). DNA collected from 15 newborns representing a range 
of Cd levels was bisulfite converted and assessed. The data show 
a significant Spearman’s rank correlation (r = 0.53, P < 0.05) 
between the MIRA-based methylation assessment and the qPCR-
based methylation for PRR13 (Fig. S2). Second, the results from 
the MIRA platform were compared with data obtained using the 
Illumina 450K platform using 2 maternal DNA samples. While 
the Spearman’s rank correlation for the genome-wide (n = 11, 347) 
assessment was not statistically significant (r = 0.01, P = 0.1), the 
methylation levels for 83 of the 92 Cd-specific genes that could be 
compared between platforms were significantly correlated (r = 0.35, 
P = 0.0009). A majority of the Cd-associated CpG islands (82%) 
had concordant relative hyper- or hypo-methylation on the 450K 
platform as compared with the MIRA assay (Table S5). Of the 20 
Cd-associated genes enriched for apoptosis, 17 could be compared 
on both platforms and these had significant Spearman’s rank 
correlation (r = 0.41, P = 0.07).
Discussion
There is growing evidence that the prenatal environment 
may influence the burden of disease in adult life, and that this 
relationship is associated with epigenetic modifications altered 
during the prenatal period.23,36 The suggested impacts of Cd 
exposure include enzyme inhibition, generation of reactive 
oxygen species, and perturbation of apoptosis or cell cycle;37 
however, the ability to induce genomic instability without 
genotoxic action has implicated a possible epigenetic mechanism 
of Cd toxicity.22 Cd-associated genome-wide DNA methylation 
has not been previously assessed in human samples. Given the 
relationship of Cd with birth outcomes in humans6,9 and its 
known role as a mediator of DNA methyltransferase activity,22 
we set out to identify whether patterns of differential promoter 
DNA methylation in fetal and maternal leukocyte DNA 
associated with exposure to Cd. The data were compared with 
cotinine-associated patterns of differential DNA methylation.
Here differences in gene-specific levels of DNA methylation 
were observed and linked to Cd exposure in utero. These genes 
were largely independent of those associated with cotinine. 
Overall, the majority of the differentially methylated genes 
showed increased or hypermethylation associated with Cd 
exposure. The Cd-associated genes were classified into their 
known ontologies, and transcription regulatory processes 
emerged as significantly enriched in both fetal and maternal 
DNA. Cell death, specifically apoptosis, was a significantly 
enriched function for each gene list. The altered Cd-associated 
DNA methylation in maternal DNA was validated using 
an alternate genome-wide approach, as well as for a subset of 
apoptosis-enriched genes. In addition, a gene-specific approach 
was used for PRR13 in fetal DNA, known to play a role in 
apoptosis.38 Cd has been shown in vitro to perturb pathways 
involved in inflammatory response, cell survival, apoptosis, 
tumorigenesis, and oxidative stress.22,39-42 In animal models, 
in utero exposure to Cd is associated with a wide range of 
Table 2. Enriched biological functions within the differentially methylated gene sets
Fetal DNA (P values) Maternal DNA (P values)
Category Function Annotation Cda Cotininea Cda Cotininea
Gene expression Regulation of transcription 0.001* [0.01] – 0.001* [0.001] –
Tissue morphology adipose tissue quantity 0.004 – – –
cancer hyperplasia 0.004 – – –
Lipid metabolismb Lipid accumulation 0.005 – – –
cell death apoptosis 0.02 [0.05] 0.001* 1.2 × 10–4* [0.04] 0.05
cell cycle Delay in G1, interphase – 3.0 × 10–5* [0.003] – –
Nervous systemc Neuronal quantity – 0.002 [0.03] 5.2 × 10–5* [0.03] –
cell proliferation Tumor proliferation – 0.002 – 0.03
protein degradation proteolysis – 0.003 [0.003] – 0.01
Infectious disease Replication of virus – – – 0.01
Neurological disease Movement disorder – – – 0.02
*P < 0.001; [ ] = P value of gene ontology terms in DaVID.aassociated contaminant exposure in fetal or maternal DNa. bLipid metabolism, molecular 
























cell cycle and proliferative genomic responses.43 The data 
presented here may support an epigenetic mechanism, namely 
DNA methylation, by which genes involved in transcriptional 
regulation and apoptosis could be influenced by Cd exposure. 
As RNA is not available for the specific study subjects 
analyzed here, gene expression analysis cannot be performed. 
It is important to note that it is not anticipated that all of the 
changes in DNA methylation will have functional consequence 
and impact gene expression.
Relative to Cd, cotinine was associated with a greater number 
of genes with differential DNA methylation in both maternal 
DNA and fetal DNA. Three previous studies of prenatal cigarette 
smoke exposure examined gene-specific DNA methylation.30-32 
One study reported global hypomethylation with gene-specific 
hypermethylation of eight genes investigated30 while the other 
found largely gene-specific hypo-methylation among 38 total 
genes.31 The third study reported 26 significant CpGs mapped 
to 10 genes with both hyper- and hypomethylation associated 
with plasma cotinine levels.32 Interestingly, none of the genes 
identified were common between the three studies and none 
are similarly reported in the present study. There are several 
factors that could potentially influence differences in observed 
DNA methylation patterns that include exposure type, 
exposure duration, tissue type (i.e., buccal vs. placental vs. cord 
blood), subject’s age at sampling, type of assay used, or other 
unaccounted for co-exposures.
It is important to mention that a woman’s current Cd levels 
may reflect prior exposure to cigarette smoke. Although we have 
accounted for cotinine exposure (a measure of recent and active 
smoking) in the analysis, it cannot be ruled out that some of the 
Cd-associated changes may be due to historic cigarette smoke 
exposure. Our data are supported by previous in vitro and ex 
vivo studies showing that Cd exposure led to hypermethylation 
of DNA after prolonged chronic exposures, whereas 
hypomethylation was present after acute Cd exposure.22,25,26
Our data highlight that regardless of exposure, there were 
significant differences in DNA methylation profiles between 
maternal and fetal samples that were not due to differences in 
maternal age, race, or infant sex. This is supported by a recent 
study that demonstrated that relative to newborn DNA, there 
is less methylation is observed among CpG island promoters 
in older individuals.15 The increased methylation levels in 
fetal DNA may have relevance for developmental biology. 
Further evaluation of these basic processes may increase our 
understanding of how early life exposures resulting in epigenetic 
shifts can have long-term health effects.
Of interest, many of the genes contained in the Cd and 
cotinine gene sets showed common sequences in their CpG 
islands within promoters. Among these conserved motif 
regions, binding sites for a common set of transcription factors 
were identified. The specific binding of transcription factors 
to target sites is a mechanism that protects CpG islands from 
methylation.44,45 Very recently studies have demonstrated 
that transcription factor binding results in local regions of 
low methylation and in contrast, absence of DNA-binding 
factors triggers the remethylation of local promoter regions,46,47 
however this phenomenon has not been described related to 
environmental exposures. Here we identify conserved motifs 
with sequence similarity to binding sites for transcription 
factors including MTF-1. Notably, MTF-1 is known to respond 
to changes in cellular concentrations of multiple metals 
and coordinate expression of genes protective against metal 
toxicity.48,49 All of the identified transcription factors (e.g., 
TCF7L1, TCFAP2E, MTF-1, SRF) are known to regulate 
developmental processes within cells and represent targets for 
future investigation.50-53 Taken together, we hypothesize that 
these results suggest that patterns of DNA methylation that 
are associated with Cd may represent “footprints” indicating 
transcription factor presence or absence that occur during 
periods of DNA methylation.
As a limitation, the cord blood sampling done here is 
representative of newborn leukocyte DNA rather than potential 
target organ systems such as the kidney, liver, or bone. There are 
obvious ethical and technical reasons to use leukocyte DNA as a 
proxy for target tissue analysis. Moreover, the use of circulating 
white blood cells as proxies for disease has been shown.54,55 
While patterns of DNA methylation can differ between white 
blood cell types,32,35,56 our data support that the Cd and cotinine 
gene sets are not simply due to shifts in blood cell types. There 
is increasing evidence that there are contaminant-specific 
changes to leukocyte DNA methylation associated with various 
environmental contaminant exposures.33,57,58 Future studies 
should aim to compare the Cd-associated changes here to tissue-
specific changes.
In summary, the data from the present study provide evidence 
of Cd- and cotinine-associated patterns in DNA methylation 
present in the leukocyte DNA of newborns and their mothers. 
We identify gene-specific changes in DNA methylation levels 
associated with in utero Cd exposure, and distinguish these 
from methylation changes attributable to cotinine exposure, 
a general proxy measure for exposure to tobacco products. 
These distinct patterns of environmentally-associated DNA 
Table 3. Transcription factors with response element sequence similarity to the identified motifs within the cd- or cotinine-associated gene sets
Fetal DNA (P values) Maternal DNA (P values)
Transcription Factor cda cotininea cda cotininea
TcFap2E 2.3 × 10–5* 9.2 × 10–4* – 4.9 × 10–3
TcF7L1 6.7 × 10–5* 2.0 × 10–5* 5.1 × 10–4* 1.5 × 10–4*
sRF 2.2 × 10–4* 3.2 × 10–4* 1.5 × 10–3 5.0 × 10–3
MTF1 3.1 × 10–4* 1.6 × 10–4* 3.5 × 10–4* 2.0 × 10–3
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methylation alterations or “footprints” in fetal and maternal 
DNA may have functional consequences in the cell and warrant 
further research. Metal exposure continues to be an important 
area of public health concern for both maternal and child health. 
Increased education about the potential risks of environmental 
contaminants including Cd and cigarette smoke will be key to 
reducing and preventing harm to infants.
Materials and Methods
Study participants
The Children’s Environmental Health Initiative (CEHI) 
conducted a prospective cohort study of pregnant women living 
in Durham County, North Carolina from 2005–2011. This study 
is a key component of the Southern Center on Environmentally-
Driven Disparities in Birth Outcomes (SCEDDBO), 
an interdisciplinary center aimed at understanding how 
environmental, social, and host factors jointly contribute to health 
disparities (http://cehi.snre.umich.edu/projects/sceddbo/). The 
CEHI Healthy Pregnancy, Healthy Baby study was reviewed 
and approved by the Institutional Review Boards at Duke 
University (Pro00007633) and the University of North Carolina 
(#09-0866). All women participating in this study consented for 
maternal venous and newborn cord blood collection for chemical 
and genetic analysis.
Women receiving prenatal care at either the Duke Obstetrics 
Clinic or the Durham County Health Department Prenatal Clinic 
were eligible to participate if they planned to deliver at Duke 
University Medical Center, were at least 18 y of age, were English-
literate, lived in Durham County, and did not have a multi-fetal 
gestation or any known fetal genetic or congenital anomalies. 
Additional methods on subject recruitment, enrollment, and data 
collection have been described previously.59 Women were enrolled 
between 18 and 28 weeks of pregnancy, and demographic data 
were collected including maternal age, race, and parity, as well 
as child’s sex and birth weight. At delivery, biological samples 
including maternal venous blood and newborn cord blood were 
collected. From the CEHI study, we selected a nested subcohort 
of 17 mother-infant pairs stratified as above or below a maternal 
Cd level of 0.2 μg/L (see Supplemental Materials).
Methylated CpG island recovery assay (MIRA)
Venous maternal blood and newborn cord blood samples 
were obtained at delivery. DNA was extracted using Qiagen’s 
PAXgene Blood DNA kit (Qiagen) according to manufacturer’s 
protocol. DNA was re-suspended in nuclease-free water and 
stored at –80 °C prior to DNA methylation assessment. CpG 
methylated DNA was collected using the MethylCollector Ultra 
Kit (Active Motif) and enriched DNA was amplified using the 
WGA3 kit (Sigma) according to manufacturer instructions 
with the following modification: 10 mM dATP, 10 mM dCTP, 
10 mM dGTP, 8 mM dTTP, and 2 mM dUTP. Amplified DNA 
was then hybridized to the Affymetrix Human Promoter 1.0R 
arrays (Affymetrix) which assess over 4.6 million sites.
Statistical Analyses
Linear regression analyses were performed using the statistical 
package SAS 9.3 (SAS Institute Inc.) to examine relationships 
between maternal blood Cd levels, serum cotinine levels and 
demographic characteristics for women and children. Maternal 
demographics included age, race, and parity, and children’s 
demographics included sex and birth weight. The relationship 
between Cd and cotinine was assessed with linear regression as 
well as Spearman rank correlation. Cd and cotinine levels below 
detect were treated as zero.
For each of the study subjects, the DNA methylation 
abundance data obtained through the MIRA assay assessing 
4.6 million probes were normalized using robust multi-chip 
average.60 The DNA methylation levels were then summarized at 
a gene-specific CpG island level annotated to the reference HG18 
where islands were defined as in Davies et al.61-63 The resulting 
average methylation abundances for 16 421 CpG islands were 
compared using ANOVA (Partek Genomic Suite 6.4) where 
differential DNA methylation levels were assessed for each 
island and statistically defined as: (1) average island promoter 
methylation with a minimum absolute change of 30%; and (2) a 
P value < 0.05. Additionally, a false discovery rate (FDR) corrected 
q-value estimate was calculated and is reported. After identifying 
covariate-associated DNA methylation patterns within CpG 
islands (see Supplemental Materials), differential methylation 
was also examined according to sample type (maternal vs. 
newborn), higher vs. lower Cd-exposed, and cotinine-exposed 
vs. cotinine-unexposed (see Supplemental Materials). The same 
statistical requirements were applied to all analyses.
Gene ontology/pathway enrichment analysis
Gene ontology/pathway enrichment analysis was performed 
using two independent methodologies. The differentially 
methylated genes were analyzed in the context of interacting 
networks using Ingenuity Pathway Analysis Software (Ingenuity 
Systems, Inc.) and functional clustering using the Database for 
Annotation, Visualization and Integrated Discovery (DAVID) 
(available online: http://david.abcc.ncifcrf.gov/tools.jsp).
Enriched DNA motif identification
CpG island sequences were retrieved from the UCSC genome 
browser website64 for each exposure-associated gene set. These 
sequences are representative of CpG islands within promoter 
regions of the genome. Position-specific letter probability 
matrices, also known as motifs, were identified using Multiple 
EM for Motif Elicitation (MEME) version 4.8.1.65 A first order 
Hidden Markov Model and negative position specific priors 
were calculated from a background set of 200 randomly selected 
CpG island sequences that were not differentially methylated. 
Additional parameter specifications are reported in the 
Supplemental Materials. The motif with the highest statistical 
significance (P value) for each group of differentially methylated 
genes was compared with known transcription factor binding 
sites using TOMTOM.65
Validation of MIRA results
For gene-specific analysis, DNA from 15 newborn leukocyte 
samples was selected. DNA was bisulfite converted using the Zymo 
EZ DNA Methylation-Lightening kit (Zymo Research) according 
to the manufacturer’s instructions. Methylation was assessed 
using the EpiTect MethyLight Assay (Qiagen). Methylation-
























apoptosis-associated gene PRR13 with forward primer sequence: 
(5′ GGTTTGGGTG ATTAGGAAGAGT 3′) and reverse 
primer sequence: (5′ AAAATCCAAA TACCCCATCA C 3′). 
A methyl-specific reporter probe for quantification was also 
designed (5′ 6FAM-GCCGCCTAAA CTTACTACGT 3′). 
The amplified region of PRR13 represents promoter region on 
chromosome 12, position 52121562–52121835, based upon 
HG18. Amplicons were assessed using qPCR in technical 
triplicate. qPCR methylation abundance was determined as 
100/(1 + cycle threshold [CT]) for each sample, averaged across 
triplicates. A Spearman rank correlation and corresponding 
P value were calculated to compare the methylation abundances 
between the qPCR and MIRA assays.
Genome-wide comparison was performed on two maternal 
DNA samples stratified by maternal blood Cd levels using 
the 0.2 μg/L exposure cutoff and matched on maternal race, 
age, and insurance status. Bisulfite conversion was performed 
using the Zymo EZ DNA Methylation kit (Zymo Research) 
according to the manufacturer’s instructions. Methylation was 
assessed at 485 577 CpGs in maternal DNA using the Illumina 
Infinium HumanMethylation450 BeadChip (Illumina Inc.). 
BeadChip processing was performed at Expression Analysis Inc. 
(www.expressionanalysis.com) and processed with Illumina’s 
GenomeStudio Methylation module Version 1.8 (Illumina 
Inc.). The proportion of methylation (β) for each CpG was 
calculated as the ratio of methylated signal intensity divided 
by the sum of both methylated and unmethylated signals. For 
quality control, probes with detection P value < 0.0001 were 
required. β values were excluded from analysis for probes which 
did not meet this minimum threshold for detection. The data 
were further filtered for probes positioned within CpG islands 
for comparison with the MIRA assay. For statistical comparison, 
average β values were calculated and a ratio of β Cd-exposed/ 
β Cd-unexposed determined for each gene. A Spearman rank 
correlation was calculated to compare the β ratio to the MIRA 
FC for all comparable genes (n = 11 347), the focused set of 92 
Cd-associated genes in maternal DNA, and the subset of 20 
Cd-associated apoptosis-related genes.
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